EarningsQ3 2025 Earnings Report

BioNano Genomics (BNGO) Q3 2025 Earnings Report

0 Followers

MX:BNGO Q3 2025 EPS Results

Actual EPS-$37.56

Consensus EPS-$38.21

Beat/MissBeat by +$0.64

One Year Ago EPS-$574.52

Actual Revenue$135.66M

Expected Revenue$127.17M

Beat/MissBeat by +$8.49M

YoY Revenue Growth+21.31%

QuarterQ3 2025

Date11/13/2025

TimeAfter Close

Conference CallThursday, November 13, 2025

MX:BNGO Upcoming Earnings

BioNano Genomics's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

MX:BNGO Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-8.29 / -	-37.565	―
Aug 10, 2026	2026 (Q2)	-12.34 / -12.15	-36.828	67.00% (+24.67)
May 13, 2026	2026 (Q1)	-16.20 / -13.99	-21.176	33.91% (+7.18)
Mar 23, 2026	2025 (Q4)	-45.58 / -28.54	-223.456	87.23% (+194.91)
Nov 13, 2025	2025 (Q3)	-38.21 / -37.56	-574.522	93.46% (+536.96)
Aug 14, 2025	2025 (Q2)	-48.93 / -36.83	-265.164	86.11% (+228.34)
May 14, 2025	2025 (Q1)	- / -	-662.91	―
Mar 31, 2025	2024 (Q4)	-55.67 / -21.18	-662.91	96.81% (+641.73)
Nov 13, 2024	2024 (Q3)	-218.23 / -574.52	-3557.618	83.85% (+2983.10)
Aug 07, 2024	2024 (Q2)	-458.84 / -265.16	-1370.014	80.65% (+1104.85)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed